Seer Inc Market Cap ($95.79 Million)
Market Cap & Net Worth: Seer Inc (SEER)
Seer Inc market cap. Seer Inc (NASDAQ:SEER) has a market capitalization of $95.79 Million ($95.79 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19185 globally and #4429 in its home market, demonstrating a -12.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Seer Inc's stock price $1.73 by its total outstanding shares 55372015 (55.37 Million). Also see SEER cash generation efficiency for how efficiently the company converts equity into cash flow.
Seer Inc Market Cap History (2020–2026)
Seer Inc market cap history from 2020 to 2026. Data shows change from $3.11 Billion to $95.79 Million (-44.53% CAGR). Check current stock price of Seer Inc for real-time trading data and today's change.
Index Memberships
Seer Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #532 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #1835 of 3165 |
Weight: Seer Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Seer Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Seer Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Seer Inc (SEER) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.29x
Seer Inc's market cap is 6.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $3.11 Billion | $656.00K | -$32.77 Million | 4738.70x | N/A |
| 2021 | $1.26 Billion | $6.39 Million | -$71.17 Million | 197.53x | N/A |
| 2022 | $321.16 Million | $14.69 Million | -$92.97 Million | 21.87x | N/A |
| 2023 | $107.42 Million | $15.18 Million | -$86.28 Million | 7.08x | N/A |
| 2024 | $127.91 Million | $13.95 Million | -$86.60 Million | 9.17x | N/A |
| 2025 | $101.33 Million | $16.12 Million | -$73.60 Million | 6.29x | N/A |
Competitor Companies of SEER by Market Capitalization
Companies near Seer Inc in the global market cap rankings as of November 3, 2026. Also see SEER total asset value for a full breakdown of the balance sheet.
Key companies related to Seer Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Seer Inc (2020–2026)
Market capitalization of Seer Inc from 2020 to today. Between 2020 and today, Seer Inc's market cap moved from $3.11 Billion to $ 95.79 Million, with a yearly change of -44.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $95.79 Million | -5.46% |
| 2025 | $101.33 Million | -20.78% |
| 2024 | $127.91 Million | +19.07% |
| 2023 | $107.42 Million | -66.55% |
| 2022 | $321.16 Million | -74.57% |
| 2021 | $1.26 Billion | -59.37% |
| 2020 | $3.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Seer Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $95.79 Million USD |
| MoneyControl | $95.79 Million USD |
| MarketWatch | $95.79 Million USD |
| marketcap.company | $95.79 Million USD |
| Reuters | $95.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more